Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for Interstitial Cystitis/Bladder Pain Syndrome
NCT05094414Phase 1Unknown
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Jul 2021
- Primary completion
- Feb 2022
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of valaciclovir in interstitial cystitis (IC) and bladder pain syndrome (BPS), sponsored by Buddhist Tzu Chi General Hospital. Primary endpoint: Global Response Assessment at 1 month. Status: unknown.
02
Drugs
valaciclovir
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT05094414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05094414.